LU34976A1 - - Google Patents

Info

Publication number
LU34976A1
LU34976A1 LU34976DA LU34976A1 LU 34976 A1 LU34976 A1 LU 34976A1 LU 34976D A LU34976D A LU 34976DA LU 34976 A1 LU34976 A1 LU 34976A1
Authority
LU
Luxembourg
Application number
Publication of LU34976A1 publication Critical patent/LU34976A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
LU34976D LU34976A1 (xx)

Publications (1)

Publication Number Publication Date
LU34976A1 true LU34976A1 (xx)

Family

ID=1768976

Family Applications (1)

Application Number Title Priority Date Filing Date
LU34976D LU34976A1 (xx)

Country Status (1)

Country Link
LU (1) LU34976A1 (xx)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088943A3 (en) * 1982-03-16 1983-12-07 Boehringer Ingelheim Vetmedica Gmbh Composition for the resorption of injected antibacterial substances and mixtures containing a benzyl amine derivative
EP0109102A3 (en) * 1982-10-15 1984-11-14 The Procter & Gamble Company Storage stable topical pharmaceutical composition including nitrogen-containing stabilizers
EP0106727A3 (en) * 1982-09-07 1985-08-14 Tetra Consultants Inc. Method of improving parenterally administerable physiologically active compositions by incorporating therein an epsilon-aminocaproic acid or tranexamic acid
EP0127468A3 (en) * 1983-05-26 1986-03-19 Takeda Chemical Industries, Ltd. Percutaneous pharmaceutical preparations for external use

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0088943A3 (en) * 1982-03-16 1983-12-07 Boehringer Ingelheim Vetmedica Gmbh Composition for the resorption of injected antibacterial substances and mixtures containing a benzyl amine derivative
EP0106727A3 (en) * 1982-09-07 1985-08-14 Tetra Consultants Inc. Method of improving parenterally administerable physiologically active compositions by incorporating therein an epsilon-aminocaproic acid or tranexamic acid
EP0109102A3 (en) * 1982-10-15 1984-11-14 The Procter & Gamble Company Storage stable topical pharmaceutical composition including nitrogen-containing stabilizers
EP0127468A3 (en) * 1983-05-26 1986-03-19 Takeda Chemical Industries, Ltd. Percutaneous pharmaceutical preparations for external use

Similar Documents

Publication Publication Date Title
AU1655388A (en) Pharmaceutical composition comprising a compound containing sulfhydryl group(s) for the treatment of otitis
ATE83379T1 (de) Coccidiozide mittel.
ATE212228T1 (de) Eine nukleinsäure enthaltende homöopatische lösung
AU1501370A (en) Improvements in or relating to organic compounds
US5399554A (en) Readily soluble 2',3'-dideoxyinosine compositions
EP0023178B1 (fr) Procédé de préparation de solutions concentrées d'amygdaline sous sa forme naturelle
AU1150888A (en) Medicament containing local anesthetics and nucleosides and its use for treating muscular injuries
AU2001268474A1 (en) Use of amp kinase activators for treatment of type 2 diabetes and insulin resistance
US4851391A (en) 5-ethyl-2-deoxyuridine and urea composition for the treatment of viral diseases
DE852123C (de) Verfahren zur Herstellung von Chloramphenicol-Loesungen
ATE77749T1 (de) Coccidiozide mittel.
ATE69551T1 (de) Zusammensetzung zur behandlung von boesartigen tumoren insbesondere bei tieren.
AT268519B (de) Verfahren zur Herstellung von hydriertem Moenomycin
ATE82128T1 (de) Pharmazeutische zusammensetzungen zur behandlung von krebs.
AU1312800A (en) Method and composition for treating ischemia and sickle cell anemia
AT328093B (de) Verfahren zur herstellung von neuen herzglykosiden
ATE123946T1 (de) Arzneimittel, enthaltend ein n6-substituiertes adenosin-derivat zur behandlung von hyperlipidämie oder hypertriglyceridämie.
AT292927B (de) Verfahren zur Herstellung von neuen Tridesoxypyranosiden
AU2001275165A1 (en) Treatment of side effects associated with alcohol consumption
US20100298252A1 (en) Methods and compositions for ophthalmic treatment of fungal and bacterial infections
GB2209938B (en) Neomycin-containing pharmaceutical compositions
AT299459B (de) Verfahren zur Herstellung von neuen Östradiol-17β-rhamnopyranosiden
AU1249595A (en) Mixtures of dideoxynucleosides and d-aspartic acid beta-hydroxamate for inhibiting retroviral spread
AU2001286744A1 (en) Compounds and methods for inhibiting neuronal cell death
AU1195076A (en) Taeniacidal agents